Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2003;89:251-253; doi:10.1136/heart.89.3.251
Copyright © 2003 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2003;89:251-253
© 2003 by BMJ Publishing Group & British Cardiac Society

REVIEW

Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator

H Solomon, J W Man, G Jackson

Department of Cardiology, 6th Floor, East Wing, St Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, UK

Correspondence to:
Dr G Jackson, Department of Cardiology, 6th Floor, East Wing, St Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, UK;
a.cooper{at}cardiocentre.u-net.com

ABSTRACT

Erectile dysfunction (ED) is a common condition and studies predict that it will become even more common in the future. There is increasing evidence to suggest that it is predominantly a vascular disease and may even be a marker for occult cardiovascular disease. The common pathological process is at the level of the endothelium, and cardiovascular risk factor control may be the key to preventing ED. Many men with established cardiovascular disease have ED. Specific guidelines for the management of ED in these patients have been produced by an expert panel. Cardiovascular risk stratification is an important initial step in managing such patients. In cardiac patients considered to have low cardiovascular risk, the management of ED can be safe and effective.

Keywords: erectile dysfunction; endothelial dysfunction


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Vardi, Y. (2009). Microvascular Complications in Diabetic Erectile Dysfunction: Do we need other alternatives?. Diabetes Care 32: S420-S422 [Full Text]  
  • Aversa, A., Bruzziches, R., Francomano, D., Natali, M., Lenzi, A. (2009). Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?. Therapeutic Advances in Urology 1: 179-197 [Abstract]  
  • Jackson, G. (2009). Erectile dysfunction in congenital heart disease. Heart 95: 1127-1127 [Full Text]  
  • Reffelmann, T., Kloner, R. A. (2009). Phosphodiesterase 5 inhibitors: are they cardioprotective?. Cardiovasc Res 83: 204-212 [Abstract] [Full Text]  
  • Traish, A. M. (2009). Androgens Play a Pivotal Role in Maintaining Penile Tissue Architecture and Erection: A Review. J Androl 30: 363-369 [Abstract] [Full Text]  
  • Jackson, G. (2009). CHAPTER 15c Erectile Dysfunction. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
  • Jamieson, F., Chalmers, J., Duncan, C., Prescott, R. J, Campbell, I. W (2008). Erectile dysfunction in type 1 diabetic males. British Journal of Diabetes & Vascular Disease 8: 232-234 [Abstract]  
  • Burnett, A. L. (2008). Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health. J Androl 29: 3-14 [Abstract] [Full Text]  
  • Miner, M. (2007). Engaging Patients in Cardiovascular Disease Risk Reduction: From Empathy to Erectile Dysfunction. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 1: 41-43 [Abstract]  
  • Jackson, G. (2006). Erectile dysfunction: a marker of silent coronary artery disease. Eur Heart J 27: 2613-2614 [Full Text]  
  • Vlachopoulos, C., Aznaouridis, K., Ioakeimidis, N., Rokkas, K., Vasiliadou, C., Alexopoulos, N., Stefanadi, E., Askitis, A., Stefanadis, C. (2006). Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 27: 2640-2648 [Abstract] [Full Text]  
  • Hellstrom, W. J.G., Egan, R. A., McGee, H. T., Clark, W. M. (2006). Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology 66: 293-294 [Full Text]  
  • Azadzoi, K. M., Master, T. A., Siroky, M. B. (2004). Effect of Chronic Ischemia on Constitutive and Inducible Nitric Oxide Synthase Expression in Erectile Tissue. J Androl 25: 382-388 [Abstract] [Full Text]  
  • Cheitlin, M. D. (2004). Erectile dysfunction: the earliest sign of generalized vascular disease?. J Am Coll Cardiol 43: 185-186 [Full Text]  
  • Bivalacqua, T. J., Usta, M. F., Champion, H. C., Kadowitz, P. J., Hellstrom, W. J. G. (2003). Endothelial Dysfunction in Erectile Dysfunction: Role of the Endothelium in Erectile Physiology and Disease. J Androl 24: S17-S37 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.